AAAAAA

   
Results: 1-10 |
Results: 10

Authors: VALENTIN JP JOVER B MAFFRE M BERTOLINO F BESSAC AM JOHN GW
Citation: Jp. Valentin et al., LOSARTAN PREVENTS THROMBOXANE A(2) PROSTANOID (TP) RECEPTOR-MEDIATED INCREASE IN MICROVASCULAR PERMEABILITY IN THE RAT, American journal of hypertension, 10(9), 1997, pp. 1058-1063

Authors: VALENTIN JP BESSAC AM MAFFRE M JOHN GW
Citation: Jp. Valentin et al., NITRIC-OXIDE REGULATION OF TP RECEPTOR-MEDIATED PULMONARY VASOCONSTRICTION IN THE ANESTHETIZED, OPEN-CHEST RAT, European journal of pharmacology, 317(2-3), 1996, pp. 335-342

Authors: VALENTIN JP BESSAC AM COLPAERT FC JOHN GW
Citation: Jp. Valentin et al., USE OF THE PITHED RAT MODEL TO DETERMINE THE RELATIVE POTENCIES OF 5-HT2A 2C RECEPTOR ANTAGONISTS FOLLOWING ACUTE INTRAVENOUS AND ORAL-ADMINISTRATION/, Methods and findings in experimental and clinical pharmacology, 17(4), 1995, pp. 267-271

Authors: BERTOLINO F VALENTIN JP MAFFRE M BESSAC AM JOHN GW
Citation: F. Bertolino et al., TXA(2) RECEPTOR ACTIVATION ELICITS ORGAN-SPECIFIC INCREASES IN MICROVASCULAR PERMEABILITY IN THE RAT, American journal of physiology. Regulatory, integrative and comparative physiology, 37(2), 1995, pp. 366-374

Authors: BERTOLINO F VALENTIN JP MAFFRE M GRELAC F BESSAC AM MACLOUF J DELHON A LEVYTOLEDANO S PATOISEAU JF COLPAERT FC JOHN GW
Citation: F. Bertolino et al., INTRINSIC ACTIVITY OF THE NONPROSTANOID THROMBOXANE A(2) RECEPTOR ANTAGONIST, DALTROBAN (BM-13,505), IN HUMAN PLATELETS IN-VITRO AND IN THERAT VASCULATURE IN-VIVO, British Journal of Pharmacology, 115(1), 1995, pp. 210-216

Authors: BERTOLINO F VALENTIN JP MAFFRE M JOVER B BESSAC AM JOHN GW
Citation: F. Bertolino et al., PREVENTION OF THROMBOXANE A(2) RECEPTOR-MEDIATED PULMONARY-HYPERTENSION BY A NONPEPTIDE ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 747-752

Authors: BERTOLINO F VALENTIN JP MAFFRE M JOVER B BESSAC AM JOHN GW
Citation: F. Bertolino et al., LOSARTAN PREVENTS THROMBOXANE-A(2) RECEPT OR-MEDIATED PULMONARY-HYPERTENSION, Archives des maladies du coeur et des vaisseaux, 87(8), 1994, pp. 971-974

Authors: RIEU JP DUFLOS A TRISTANI JC PATOISEAU JF TISNEVERSAILLES J BESSAC AM BONNAFOUS R MARTY A VERSCHEURE Y BIGG DCH
Citation: Jp. Rieu et al., SYNTHESIS AND BRADYCARDIAC ACTIVITY OF A SERIES OF SUBSTITUTED 3-AMINOALKYL-2,3-DIHYDRO-4H-1,3-BENZOXAZIN-4-ONES AS POTENT ANTIISCHEMICS, European journal of medicinal chemistry, 28(9), 1993, pp. 683-691

Authors: VALENTIN JP BERTOLINO F MAFFRE M JOVER B BESSAC AM JOHN GW
Citation: Jp. Valentin et al., PREVENTION OF THROMBOXANE-A2 (TXA2) RECEPTOR-MEDIATED PULMONARY-HYPERTENSION AND PLASMA EXUDATION BY A NONPEPTIDE ANGIOTENSIN-II TYPE-1 (AT1) RECEPTOR ANTAGONIST, Hypertension, 22(3), 1993, pp. 441-441

Authors: BERTOLINO F VALENTIN JP MAFFRE M BESSAC AM JOHN GW
Citation: F. Bertolino et al., THROMBOXANE-A2 (TXA2) RECEPTOR ACTIVATION ELICITS ORGAN-SPECIFIC INCREASES IN TRANSCAPILLARY SHIFT OF FLUID AND PROTEINS IN THE RAT, Circulation, 88(4), 1993, pp. 37-37
Risultati: 1-10 |